Related Experiment Video
Updated: Jun 28, 2026
09:01
Non-invasive Assessment of the Efficacy of New Therapeutics for Intestinal Pathologies Using Serial Endoscopic Imaging of Live Mice
Published on: March 10, 2015
Antitumor efficacy testing in rodents
1Biological Testing Branch, Developmental Therapeutics Program, Fairview Center, Frederick, MD 21701, USA. hollingm@mail.nih.gov
Journal of the National Cancer Institute
|October 30, 2008
Summary
Optimizing preclinical rodent efficacy studies is crucial for reducing the high costs of anticancer drug development. Improving model selection, endpoints, and statistical analysis can prevent costly errors in clinical trial selection.
Area of Science:
- Oncology
- Pharmacology
- Biostatistics
Background:
- Anticancer therapeutic development involves costly preclinical research and human clinical trials.
- Preclinical rodent efficacy studies significantly contribute to these costs and guide clinical development decisions.
- Inaccurate recommendations from preclinical studies lead to increased development expenses.
Purpose of the Study:
- To discuss critical issues in preclinical rodent efficacy studies for anticancer therapeutics.
- To highlight areas for improvement in experimental design and data evaluation.
- To reduce overall costs associated with anticancer drug development.
Main Methods:
- Identification of appropriate preclinical efficacy models.
- Selection of suitable experimental endpoints.
- Correct statistical evaluation of data.
- Consideration of experimental design factors: drug vehicle, treatment plan, statistical power, and randomization.
Main Results:
- Discussion of key factors influencing the accuracy and reliability of preclinical rodent efficacy studies.
- Emphasis on the need for rigorous experimental design and statistical analysis.
- Identification of areas where improvements can enhance the predictive value of preclinical studies.
Conclusions:
- Improved preclinical selection criteria can significantly reduce unnecessary human studies.
- Optimizing preclinical studies aids in lowering the overall costs of anticancer drug development.
- Enhancing the quality of preclinical research is essential for efficient therapeutic advancement.
Related Concept Videos
02:43Mouse Models of Cancer Study
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
01:23Toxicity Testing in Animals
Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...